PPARα activator irbesartan suppresses the proliferation of endometrial carcinoma cells via SREBP1 and ARID1A
Article in Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics (May 2023)
The most recent citing publications are shown below. View all 9 publications that cite this research output on Dimensions.
Article in Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics (May 2023)
Preprint in bioRxiv (November 2021)
Preprint in bioRxiv (October 2021)